RE:RE:RE:Multiple thoughts.I don't want to be CEO... thanks for the suggestion but I'm quite content in my role thanks...
My point is simply that Matt failed to reduce time to market, by running all the additional trials since the SPA was granted. They didn't HAVE to do those... FDA gave recommendations sure (and we only have ONCY's word on that).
But why would Matt claim that the Aware-1 trial data was all that was needed for Roche to pull the trigger... they haven't... He ran Bracelet-1 not because he needed to, but to generate competive bidding - that failed spectacularly, and then we find out after the event that the triplet combo could be expected to be worse... that's a BIG fail.
I just want the record straight on his performance... I'm not saying I would do better, but I am not in his role, nor do I have the inside info he is privvy to.
Whilst we deliberate, the stocks I bought to replace 1/2 the ONCY position I once had are flying. This is just too risky until Ph III funding question is answered.